Justin Danilewitz Comments on Fraud Case in MarketWatch Article

Justin Danilewitz Comments on Fraud Case in MarketWatch Article
SEC called Theranos fraud ‘massive’ - but didn’t get the company or its founder to admit guilt
March 16, 2018
Francine McKenna
MarketWatch

Justin Danilewitz, a partner in the Firm’s White Collar and Government Litigation Practice, is quoted in this article discussing the Securities and Exchange Commission’s treatment of a recent fraud investigation into Theranos.

“Not requiring an admission of guilt in this case is certainly more consistent with the retreat from that approach signaled by Co-Director of Enforcement Steven Peikin in remarks last fall,” said Justin.

To read the full article, click here.